null

SMILES NC(=O)[C@H]1CC[C@H]2CN1C(=O)N2OS(=O)(=O)O[Na]

InChI Key InChIKey=RTCIKUMODPANKX-UYXJWNHNSA-M

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 159601   

TargetBeta-lactamase(Escherichia coli)
MEIJI SEIKA PHARMA CO., LTD.

US Patent
LigandPNGBDBM159601(US8772490, Example 24 | US9035062, 24)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.0Assay Description:For the measurement of β-lactamase inhibitory activity, 100 μM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% D...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KP80XXUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM159601(US8772490, Example 24 | US9035062, 24)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent
TargetBeta-lactamase(Pseudomonas aeruginosa (PAO1))
Meiji Seika Pharma Co., Ltd.

US Patent
LigandPNGBDBM159601(US8772490, Example 24 | US9035062, 24)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NK3CWQUS Patent